Intervention Review

Vitamin K supplementation for cystic fibrosis

  1. Vanitha A Jagannath1,*,
  2. Zbys Fedorowicz2,
  3. Vidhu Thaker3,
  4. Anne B Chang4

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 19 JAN 2011

Assessed as up-to-date: 13 OCT 2010

DOI: 10.1002/14651858.CD008482.pub2

Database Title

Additional Information

How to Cite

Jagannath VA, Fedorowicz Z, Thaker V, Chang AB. Vitamin K supplementation for cystic fibrosis. Cochrane Database of Systematic Reviews 2011, Issue 1. Art. No.: CD008482. DOI: 10.1002/14651858.CD008482.pub2.

Author Information

  1. 1

    KIMS Bahrain Medical Center, Department of Paediatrics, Manama, Bahrain

  2. 2

    Ministry of Health, Bahrain, UKCC (Bahrain Branch), Awali, Bahrain

  3. 3

    Haverstraw Pediatrics, Haverstraw, NY, USA

  4. 4

    Queensland Children's Respiratory Centre and Queensland Children's Medical Research Institute, Royal Children's Hospital, Brisbane and Menzies School of Health Research, CDU, Darwin, Brisbane, Queensland, Australia

*Vanitha A Jagannath, Department of Paediatrics, KIMS Bahrain Medical Center, Um al Hassam Ave, Adliya, Manama, PO Box 175829, Bahrain. kidzdoc311@gmail.com. kidzdoc311@yahoo.co.in.

Publication History

  1. Publication Status: New
  2. Published Online: 19 JAN 2011

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (59K)Standard (308K)Full (325K)

  1. Current Version

    Vitamin K supplementation for cystic fibrosis

    Vanitha A Jagannath, Zbys Fedorowicz, Vidhu Thaker and Anne B Chang

    Article first published online: 19 JAN 2011 | DOI: 10.1002/14651858.CD008482.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Vitamin K supplementation for cystic fibrosis

    Vanitha A Jagannath, Zbys Fedorowicz, Vidhu Thaker, Anne B Chang and Nutayla Al-Harthy

    Article first published online: 14 APR 2010 | DOI: 10.1002/14651858.CD008482

View Full Article (HTML) Summary (59K)Standard (308K)Full (325K)